Abstract
The premature infant is at increased risk of cerebral white matter injury. Melatonin is neuroprotective in adult models of focal cerebral ischemia and attenuates ibotenate-induced white matter cysts in neonatal mice. Clinically, melatonin has been used to treat sleep disorders in children without major side effects. The aim of this study was to investigate the protective and anti-inflammatory effects of melatonin in the immature brain following intrauterine asphyxia. Fetal sheep at 90 d of gestation were subjected to umbilical cord occlusion. Melatonin (20 mg/kg, n = 9) or vehicle (n = 10) was administered IV to the fetus, starting 10 min after the start of reperfusion and continued for 6 h. Melatonin treatment resulted in a slower recovery of fetal blood pressure following umbilical cord occlusion, but without changes in fetal heart rate, acid base status or mortality. The production of 8-isoprostanes following umbilical cord occlusion was attenuated and there was a reduction in the number of activated microglia cells and TUNEL-positive cells in melatonin treated fetuses, suggesting a protective effect of melatonin. In conclusion, this study shows that melatonin attenuates cell death in the fetal brain in association with a reduced inflammatory response in the blood and the brain following intrauterine asphyxia in mid-gestation fetal sheep.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- FHR:
-
fetal heart rate
- FMAP:
-
fetal mean arterial blood pressure
- PVL:
-
periventricular leukomalacia
References
Banker BQ, Larroche JC 1962 Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy. Arch Neurol 7: 386–410
Perlman JM 1998 White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Hum Dev 53: 99–120
Volpe JJ 2001 Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50: 553–562
Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ 2005 Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365: 663–670
Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH 2005 Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353: 1574–1584
Claustrat B, Brun J, Chazot G 2005 The basic physiology and pathophysiology of melatonin. Sleep Med Rev 9: 11–24
Herxheimer A, Petrie KJ 2002 Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev 2: CD001520
Jan MM 2000 Melatonin for the treatment of handicapped children with severe sleep disorders. Pediatr Neurol 23: 229–232
Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I 2001 Effects of melatonin treatment in septic newborns. Pediatr Res 50: 756–760
Fulia F, Gitto E, Cuzzocrea S, Reiter RJ, Dugo L, Gitto P, Barberi S, Cordaro S, Barberi I 2001 Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 31: 343–349
Macleod MR, O'Collins T, Horky LL, Howells DW, Donnan GA 2005 Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. J Pineal Res 38: 35–41
Chung SY, Han SH 2003 Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J Pineal Res 34: 95–102
Husson I, Mesples B, Bac P, Vamecq J, Evrard P, Gressens P 2002 Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 51: 82–92
Watanabe K, Wakatsuki A, Shinohara K, Ikenoue N, Yokota K, Fukaya T 2004 Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain. J Pineal Res 37: 276–280
Mallard C, Welin AK, Peebles D, Hagberg H, Kjellmer I 2003 White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res 28: 215–223
Welin AK, Sandberg M, Lindblom A, Arvidsson P, Nilsson UA, Kjellmer I, Mallard C 2005 White matter injury following prolonged free radical formation in the 0.65 gestation fetal sheep brain. Pediatr Res 58: 100–105
Ahola T, Fellman V, Laaksonen R, Laitila J, Lapatto R, Neuvonen PJ, Raivio KO 1999 Pharmacokinetics of intravenous N-acetylcysteine in pre-term new-born infants. Eur J Clin Pharmacol 55: 645–650
Mallard EC, Williams CE, Gunn AJ, Gunning MI, Gluckman PD 1993 Frequent episodes of brief ischemia sensitize the fetal sheep brain to neuronal loss and induce striatal injury. Pediatr Res 33: 61–65
Miller SL, Yan EB, Castillo-Melendez M, Jenkin G, Walker DW 2005 Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev Neurosci 27: 200–210
Reiter RJ, Calvo JR, Karbownik M, Qi W, Tan DX 2000 Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917: 376–386
McRae A, Gilland E, Bona E, Hagberg H 1995 Microglia activation after neonatal hypoxic-ischemia. Brain Res Dev Brain Res 84: 245–252
Mesples B, Plaisant F, Fontaine RH, Gressens P 2005 Pathophysiology of neonatal brain lesions: lessons from animal models of excitotoxicity. Acta Paediatr 94: 185–190
Hedtjarn M, Mallard C, Hagberg H 2004 Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab 24: 1333–1351
Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, Chi JG 1997 High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 177: 406–411
Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H 2002 Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 22: 5910–5919
Hedtjarn M, Mallard C, Iwakura Y, Hagberg H 2005 Combined deficiency of IL-1beta18, but not IL-1alphabeta, reduces susceptibility to hypoxia-ischemia in the immature brain. Dev Neurosci 27: 143–148
Hedtjarn M, Mallard C, Arvidsson P, Hagberg H 2005 White matter injury in the immature brain: role of interleukin-18. Neurosci Lett 373: 16–20
Dringen R 2005 Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 7: 1223–1233
Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, Volpe JJ, Kinney HC 2003 Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 62: 441–450
Inder T, Mocatta T, Darlow B, Spencer C, Volpe JJ, Winterbourn C 2002 Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr Res 52: 213–218
Ahola T, Fellman V, Kjellmer I, Raivio KO, Lapatto R 2004 Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr Res 56: 88–93
Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM 2004 Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 43: 192–197
Lusardi P, Preti P, Savino S, Piazza E, Zoppi A, Fogari R 1997 Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects. Blood Press Monit 2: 99–103
Doolen S, Krause DN, Dubocovich ML, Duckles SP 1998 Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 345: 67–69
Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C 1999 Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 50: 271–279
Papavasiliou PS, Cotzias GC, Duby SE, Steck AJ, Bell M, Lawrence WH 1972 Melatonin and parkinsonism. JAMA 221: 88–89
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Swedish Medical Research Council (K2004-33X-14185-03A), Åhlen Foundation, Sven Jerring Foundation, Magnus Bergvall Foundation, Wilhelm and Martina Lundgren Foundation, Linnéa and Josef Carlsson Foundation, Frimurare Barnhus Foundation, Göteborg Medical Society, Swedish governmental grants to scientists working in health care (ALFGBG-2863) and Åke Wibergs Foundation.
Rights and permissions
About this article
Cite this article
Welin, AK., Svedin, P., Lapatto, R. et al. Melatonin Reduces Inflammation and Cell Death in White Matter in the Mid-Gestation Fetal Sheep Following Umbilical Cord Occlusion. Pediatr Res 61, 153–158 (2007). https://doi.org/10.1203/01.pdr.0000252546.20451.1a
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.pdr.0000252546.20451.1a
This article is cited by
-
Neuroprotective effects of maternal melatonin administration in early-onset placental insufficiency and fetal growth restriction
Pediatric Research (2024)
-
Effects of fetal growth restriction on the perinatal neurovascular unit and possible treatment targets
Pediatric Research (2024)
-
MicroRNA-210 downregulates TET2 and contributes to inflammatory response in neonatal hypoxic-ischemic brain injury
Journal of Neuroinflammation (2021)
-
COHESION: core outcomes in neonatal encephalopathy (protocol)
Trials (2021)
-
Partial protective effects of melatonin on developing brain in a rat model of chorioamnionitis
Scientific Reports (2021)
